A clinical-stage biotechnology company developing conjugate vaccines aimed at preventing serious bacterial infections. Its pipeline is focused on next‑generation pneumococcal vaccines designed to provide broader strain coverage than existing products, with multiple candidates in clinical development...
Market Cap: $7.9B52W Range: $27.66 – $76.61
This page tracks all publicly disclosed congressional trades in Vaxcyte, Inc. (PCVX), a company in the Healthcare sector. 2 members of Congress have disclosed trades in this stock, including 4 purchases and 1 sale. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.